These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7491375)

  • 1. Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder.
    Paige SR; Hendricks SE; Fitzpatrick DF; Balogh S; Burke WJ
    Psychopharmacol Bull; 1995; 31(2):243-8. PubMed ID: 7491375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in heart rate variability with successful treatment in patients with major depressive disorder.
    Balogh S; Fitzpatrick DF; Hendricks SE; Paige SR
    Psychopharmacol Bull; 1993; 29(2):201-6. PubMed ID: 8290666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Event-related potential amplitude/intensity slopes predict response to antidepressants.
    Paige SR; Fitzpatrick DF; Kline JP; Balogh SE; Hendricks SE
    Neuropsychobiology; 1994; 30(4):197-201. PubMed ID: 7862269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.
    Neuhaus AH; Luborzewski A; Rentzsch J; Brakemeier EL; Opgen-Rhein C; Gallinat J; Bajbouj M
    J Affect Disord; 2007 Jun; 100(1-3):123-8. PubMed ID: 17098290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.
    Jamerson BD; Krishnan KR; Roberts J; Krishen A; Modell JG
    Psychopharmacol Bull; 2003; 37(2):67-78. PubMed ID: 14566216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response to sleep deprivation and auditory-evoked potentials--preliminary results.
    Danos P; Kasper S; Scholl HP; Kaiser J; Ruhrmann S; Höflich G; Möller HJ
    Pharmacopsychiatry; 1994 Mar; 27(2):70-1. PubMed ID: 8029315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of bupropion in winter depression: results of an open trial.
    Dilsaver SC; Qamar AB; Del Medico VJ
    J Clin Psychiatry; 1992 Jul; 53(7):252-5. PubMed ID: 1639745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components.
    Linka T; Sartory G; Gastpar M; Scherbaum N; Müller BW
    Psychiatry Res; 2009 Sep; 169(2):139-43. PubMed ID: 19700202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
    Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
    J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
    Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
    Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
    Walker PW; Cole JO; Gardner EA; Hughes AR; Johnston JA; Batey SR; Lineberry CG
    J Clin Psychiatry; 1993 Dec; 54(12):459-65. PubMed ID: 8276736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion in tricyclic antidepressant nonresponders with unipolar major depressive disorder.
    Ferguson J; Cunningham L; Merideth C; Apter J; Feighner J; Ionescu-Pioggia M; Samara B; Johnston JA; Ascher J
    Ann Clin Psychiatry; 1994 Sep; 6(3):153-60. PubMed ID: 7881495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
    Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.